Izadi Fereshteh, Zamanian-Azodi Mona, Mansouri Vahid, Khodadoostan Mahsa, Naderi Nosratollah
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Proteomics Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gastroenterol Hepatol Bed Bench. 2017 Summer;10(3):184-193.
The main goal of this analysis was prioritization of co-expressed genes and miRNAs that are thought to have important influences in the pathogenesis of colon and lung cancers.
MicroRNAs (miRNAs) as small and endogenous noncoding RNAs which regulate gene expression by repressing mRNA translation or decreasing stability of mRNAs; they have proven pivotal roles in different types of cancers. Accumulating evidence indicates the role of miRNAs in a wide range of biological processes from oncogenesis and tumor suppressors to contribution to tumor progression. Colon and lung cancers are frequently encountered challenging types of cancers; therefore, exploring trade-off among underlying biological units such as miRNA with mRNAs will probably lead to identification of promising biomarkers involved in these malignancies.
Colon cancer and lung cancer expression data were downloaded from Firehose and TCGA databases and varied genes extracted by DCGL software were subjected to build two gene regulatory networks by parmigene R package. Afterwards, a network-driven integrative analysis was performed to explore prognosticates genes, miRNAs and underlying pathways.
A total of 192 differentially expressed miRNAs and their target genes within gene regulatory networks were derived by ARACNE algorithm. BTF3, TP53, MYC, CALR, NEM2, miR-29b-3p and miR-145 were identified as bottleneck nodes and enriched via biological gene ontology (GO) terms and pathways chiefly in biosynthesis and signaling pathways by further screening.
Our study uncovered correlated alterations in gene expression that may relate with colon and lung cancers and highlighted the potent common biomarker candidates for the two diseases.
本分析的主要目标是对那些被认为在结肠癌和肺癌发病机制中具有重要影响的共表达基因和微小RNA(miRNA)进行优先级排序。
微小RNA(miRNAs)是小型内源性非编码RNA,通过抑制mRNA翻译或降低mRNA稳定性来调节基因表达;它们已被证明在不同类型的癌症中起关键作用。越来越多的证据表明,miRNAs在从肿瘤发生、肿瘤抑制到肿瘤进展的广泛生物学过程中发挥作用。结肠癌和肺癌是常见的具有挑战性的癌症类型;因此,探索诸如miRNA与mRNA等潜在生物学单元之间的权衡,可能会导致发现参与这些恶性肿瘤的有前景的生物标志物。
从Firehose和TCGA数据库下载结肠癌和肺癌表达数据,并使用DCGL软件提取的不同基因通过parmigene R包构建两个基因调控网络。之后,进行网络驱动的综合分析以探索预后基因、miRNAs和潜在途径。
通过ARACNE算法在基因调控网络中总共获得了192个差异表达的miRNAs及其靶基因。通过进一步筛选,BTF3、TP53、MYC、CALR、NEM2、miR-29b-3p和miR-145被确定为瓶颈节点,并主要通过生物基因本体(GO)术语和生物合成及信号通路中的途径进行富集。
我们的研究揭示了可能与结肠癌和肺癌相关的基因表达相关变化,并突出了这两种疾病潜在的共同生物标志物候选物。